Studies using breast cancer cell lines (including MDA-MB-231) have demonstrated that the MCAM gene is regulated by promoter methylation and that treatment with demethylating agents enhances MCAM gene expression and expression of CD146 (Dudzik et al., 2019). This evidence concerns the gene MCAM and breast cancer.